Skip to main content
Log in

Serum IgM level as an index of malignancy in brain tumours

  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

Serum IgG, IgA, and IgM levels have been measured in patients with brain tumours. Only in astrocytomas have significant differences been found with respect to the other brain tumours. The specific elevation of IgM levels in astrocytoma grade III (X=313+36, n=4) and astrocytoma grade IV (X=671+ 146, n=4) in comparison with astrocytoma grade II (X=180, n=2) shows clear correlation with the malignancy of astrocytomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Berkay, F., Sayin, E., Demirkaya, E., Hekim, N., Determination of serum immunoglobulin levels in patients with brain tumours and neurological disorders (1980). In preparation.

  • Guzel, Ö. (unpublished observations).

  • Mahaley, M. S., Brooks, W. H., Roszman, T. L., Bigner, D. D., Dudka, L., Richardson, S., Immunobiology of primary intracranial tumours, Part I. Studies of the cellular and humoral general immune competence of brain tumour patients. J. Neurosurg.46 (1977), 467–476.

    PubMed  Google Scholar 

  • Tokumaru, T., Catalano, L. W., Elevation of serum immunoglobulin M level in patients with brain tumours. Surg. Neurol.4 (1975), 17–21.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hekim, N., Sayin, E., Demirkaya, E. et al. Serum IgM level as an index of malignancy in brain tumours. Acta neurochir 59, 227–230 (1981). https://doi.org/10.1007/BF01406352

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01406352

Keywords

Navigation